F-1: SMX (Security Matters) Seeks to Resell 628,232 Ordinary Shares; Awaits Potential $1.3 Million from Warrant Exercises

Sentiment:

Resale Registration Statement


SMX (Security Matters) is registering for resale up to 628,232 ordinary shares by a selling stockholder, while anticipating potential proceeds from warrant exercises.

Capital raiseThe company is registering for resale up to 628,232 ordinary shares by a selling stockholder.The company could receive up to $1,299,104.50 from warrant exercises.The company has a Stock Purchase Agreement with Generating Alpha Ltd. committing Alpha to purchase up to $30,000,000 of SMX's ordinary shares.

Summary

  • SMX (Security Matters) Public Limited Company has filed a registration statement for the resale of up to 628,232 ordinary shares by a selling stockholder.
  • The shares consist of those potentially received from the conversion of a $1,150,000 convertible promissory note and shares underlying warrants with an exercise price of $6.23 per share.
  • The company will not receive any proceeds from the resale of shares by the selling stockholder.
  • However, SMX could receive up to approximately $1,299,104.50 from the cash exercise of the warrants.
  • The company is an emerging growth company and a foreign private issuer, which allows for reduced disclosure requirements.
  • Recent developments include a securities purchase agreement, a reverse stock split, a PMB Partners LOI, Canterbury Bridge Financing and Rescission, share issuances to certain debtholders, and a partnership with Brinks.

Sentiment

Score: 4

Explanation: The document focuses on a resale registration, which is generally neutral. However, the company's financial situation and reliance on future capital raises introduce some uncertainty.

Positives

  • Potential for $1,299,104.50 in proceeds from warrant exercises.
  • Partnership with Brinks to enhance gold marking and auditing.
  • Stock Purchase Agreement with Generating Alpha Ltd. commits Alpha to purchase up to $30,000,000 of SMX's ordinary shares.

Negatives

  • The company will not receive any proceeds from the resale of shares by the selling stockholder.
  • The company has incurred and continues to incur losses and continues to generate negative cash flows from operations since inception in 2015.
  • The company is subject to a number of risks, including the ability to maintain the listing of the Ordinary Shares on Nasdaq.

Risks

  • The company may not be able to maintain the listing of the Ordinary Shares on Nasdaq.
  • The company may need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all.
  • The company may experience difficulties in managing its growth and expanding operations.
  • The company may be adversely affected by other economic, business, and/or competitive factors.
  • The company may be unable to, and it may be difficult and costly to, obtain, maintain, protect, or enforce our intellectual property and other proprietary rights sufficiently.

Future Outlook

The company expects that its existing cash and cash equivalents, along with amounts it may draw down from time to time under the $30,000,000 SPA, and receivables from clients once paid, will be sufficient to fund its operations for the foreseeable future but perhaps at a delayed or reduced scope.

Industry Context

The document relates to the anti-counterfeit and track-and-trace industry, which is subject to global and domestic competition. The company aims to establish itself as a market standard for circular economy solutions, brand authentication, and supply chain integrity.

Related Party Transactions

  • The document mentions several related party transactions, including agreements with Lionheart Equities, LLC, and certain shareholders.
  • The document mentions several related party transactions, including agreements with PMB Partners, LP, and certain shareholders.

Stakeholder Impact

  • Shareholders may experience dilution from future equity issuances.
  • The company's ability to execute its business plan depends on securing additional funding.
  • The company's financial condition and results of operations could be materially adversely affected if any of the risks outlined in the Risk Factors section actually occurs.

Next Steps

  • The Selling Stockholder may sell the Ordinary Shares at prevailing market or privately negotiated prices.
  • The company will use its best efforts to file with the SEC a registration statement for the registration under the Securities Act of the Ordinary Shares issuable upon exercise of the Public Warrants and thereafter will use its best efforts to cause the same to become effective within 60 business days following the closing of the Transactions and to maintain a current prospectus relating to the Ordinary Shares issuable upon exercise of the Public Warrants, until the expiration of the Public Warrants in accordance with the provisions of that certain warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and Lionheart (the Warrant Agreement).

Key Dates

DateDescription
2015-01-01SMX Israel entered a license agreement with Isorad Ltd
2022-07-26Business Combination Agreement between SMX, Lionheart III Corp., and Aryeh Merger Sub, Inc.
2023-03-07Company consummated its previously announced business combination
2023-10-03Security Matters PTY entered into the Investment Agreement with trueGold
2024-07-10Company entered into the LOI with PMB Partners, LP
2024-08-13Closing price of Ordinary Shares was $3.01

Keywords

Ordinary Shares, Resale, Warrants, Convertible Note, Emerging Growth Company, Financial Results, SMX, Security Matters, Stock Purchase Agreement, Reverse Stock Split

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.